- Home
- MNDO vs OKYO Comparison
MNDO vs OKYO Comparison
Compare MNDO & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDO
- OKYO
- Stock Information
- Founded
- MNDO 1995
- OKYO 2007
- Country
- MNDO Israel
- OKYO United Kingdom
- Employees
- MNDO N/A
- OKYO N/A
- Industry
- MNDO EDP Services
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNDO Technology
- OKYO Health Care
- Exchange
- MNDO Nasdaq
- OKYO Nasdaq
- Market Cap
- MNDO 34.2M
- OKYO 37.0M
- IPO Year
- MNDO 2000
- OKYO 2022
- Fundamental
- Price
- MNDO $1.34
- OKYO $2.45
- Analyst Decision
- MNDO
- OKYO Strong Buy
- Analyst Count
- MNDO 0
- OKYO 1
- Target Price
- MNDO N/A
- OKYO $7.00
- AVG Volume (30 Days)
- MNDO 40.6K
- OKYO 215.4K
- Earning Date
- MNDO 08-05-2025
- OKYO 08-12-2025
- Dividend Yield
- MNDO 16.06%
- OKYO N/A
- EPS Growth
- MNDO N/A
- OKYO N/A
- EPS
- MNDO 0.17
- OKYO N/A
- Revenue
- MNDO $20,677,000.00
- OKYO N/A
- Revenue This Year
- MNDO N/A
- OKYO N/A
- Revenue Next Year
- MNDO N/A
- OKYO N/A
- P/E Ratio
- MNDO $7.79
- OKYO N/A
- Revenue Growth
- MNDO N/A
- OKYO N/A
- 52 Week Low
- MNDO $1.31
- OKYO $0.81
- 52 Week High
- MNDO $2.13
- OKYO $3.11
- Technical
- Relative Strength Index (RSI)
- MNDO 30.99
- OKYO 58.01
- Support Level
- MNDO $1.33
- OKYO $2.05
- Resistance Level
- MNDO $1.37
- OKYO $2.49
- Average True Range (ATR)
- MNDO 0.03
- OKYO 0.31
- MACD
- MNDO -0.00
- OKYO -0.01
- Stochastic Oscillator
- MNDO 11.11
- OKYO 44.44
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.